Sickle Cell Trait or Sickle Cell Disease Associated with Increased Diabetic Retinopathy Risk
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Christina Ambrosino (ORCID: https://orcid.org/0000-0002-0171-6815)
- Adrienne W. Scott (ORCID: https://orcid.org/0000-0003-2607-1184)
- Ximin Li (ORCID: https://orcid.org/0000-0002-0460-6515)
- Ann Nampomba
- J. Mcdonald
Institutions
- Mayo Clinic (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1016/j.xops.2025.100756
- Citations
- 1
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Research to Prevent Blindness
- Johns Hopkins University
- Regeneron Pharmaceuticals
- American Academy of Ophthalmology
- Apellis Pharmaceuticals
- Astellas Pharma
- National Institutes of Health
- Genentech
- Allergan
- School of Medicine, Johns Hopkins University